Agios Pharmaceuticals (AGIO) announced the appointment of Tsveta Milanova to the role of chief commercial officer, effective Jan. 3, 2023. Ms. Milanova will succeed Richa Poddar, who has been with Agios since 2016 and will continue to serve as the company’s chief commercial officer until the end of the year. Milanova spent five years at Alexion in high-impact commercial and market access roles, including senior vice president, head of U.S. commercial; senior vice president, global commercial strategy; and senior vice president, global value, access and policy.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AGIO:
- Agios Appoints Tsveta Milanova as Chief Commercial Officer
- Agios to Participate in December Investor Conference
- PYRUKYND® (mitapivat) Approved in the EU for the Treatment of Pyruvate Kinase (PK) Deficiency in Adult Patients
- Agios Reports Business Highlights and Third Quarter 2022 Financial Results
- Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty
